{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:48:05Z","timestamp":1761965285409,"version":"3.40.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,23]],"date-time":"2021-05-23T00:00:00Z","timestamp":1621728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,23]],"date-time":"2021-05-23T00:00:00Z","timestamp":1621728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Blastic plasmacytoid dendritic cell neoplasm represents a rare type of hematologic malignancy that often manifests itself through various skin lesions. It commonly affects the elderly male population. Lymph nodes, peripheral blood, and bone marrow involvement are the typical findings that justify its aggressive nature and dismal prognosis. On histopathological assessment, malignant cells share some similarities with blastic cells from the myeloid lineage that make immunohistochemistry staining mandatory for blastic plasmacytoid dendritic cell neoplasm diagnosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 35-year-old Asian man presented with cervical lymphadenopathy followed by an erythematous lesion on his left upper back. At first, the lesion was misdiagnosed as an infectious disease and made the patient receive two ineffective courses of azithromycin and clarithromycin. Six months later, besides persistent skin manifestations, he felt a cervical mass, which was misdiagnosed as follicular center cell lymphoma. Tumor recurrence following the chemoradiation questioned the diagnosis, and further pathologic assessments confirmed blastic plasmacytoid dendritic cell neoplasm. The second recurrence occurred 3\u00a0months after chemotherapy. Eventually, he received a bone marrow transplant after complete remission. However, the patient expired 3\u00a0months after transplant owing to the third recurrence and gastrointestinal graft versus host disease complications.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Early clinical suspicion and true pathologic diagnosis play a crucial role in patients\u2019 prognosis. Moreover, allogenic bone marrow transplant should be performed with more caution in aggressive forms of blastic plasmacytoid dendritic cell neoplasm because of transplant side effects and high risk of cancer recurrence.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-021-02860-z","type":"journal-article","created":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T23:05:37Z","timestamp":1621724737000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A misdiagnosed case of blastic plasmacytoid dendritic cell neoplasm experiencing multiple recurrences who\u00a0underwent allogeneic stem cell transplantation: a case report"],"prefix":"10.1186","volume":"15","author":[{"given":"Fateme","family":"Salemi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mohammad Reza","family":"Mortazavizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5593-3743","authenticated-orcid":false,"given":"Seyyedmohammadsadeq","family":"Mirmoeeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3630-5028","authenticated-orcid":false,"given":"Amirhossein","family":"Azari Jafari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farid","family":"Kosari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Sina","family":"Naghibi Irvani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,23]]},"reference":[{"issue":"4","key":"2860_CR1","doi-asserted-by":"publisher","first-page":"456","DOI":"10.2340\/00015555-3141","volume":"99","author":"CL Yang","year":"2019","unstructured":"Yang CL, Zhao S, Wang L, Zou LQ. Blastic plasmacytoid dendritic cell neoplasm: a case report. Acta Derm Venereol. 2019;99(4):456\u20137.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"2860_CR2","first-page":"1127","volume":"12","author":"T Wang","year":"2019","unstructured":"Wang T, Liu L, Zhang RY, Guo J. Lymph blastic plasmacytoid dendritic cell neoplasm: a case report and review of literature. Int J Clin Exp Med. 2019;12(1):1127\u201331.","journal-title":"Int J Clin Exp Med"},{"key":"2860_CR3","unstructured":"World Health Organization. WHO Classification of tumours of haematopoietic and lymphoid tissues, Fourth Edition. 2008."},{"key":"2860_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/ddg.13784","volume":"17","author":"Y Mansour","year":"2019","unstructured":"Mansour Y, Stadler R. Blastic plasmacytoid dendritic cell neoplasm, a rare hematological manifestation of the skin. JDDG. 2019;17:61.","journal-title":"JDDG"},{"issue":"8","key":"2860_CR5","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/cup.13257","volume":"45","author":"V Szablewski","year":"2018","unstructured":"Szablewski V, Costes V, Bret C, Dereure O, Yosr H, Alame M, et\u00a0al. Cutaneous presentation preceding acute myeloid leukemia with CD4+\/CD56+expression misdiagnosed as a blastic plasmocytoid dendritic cell neoplasm: a case report. J Cutan Pathol. 2018;45(8):610\u20134.","journal-title":"J Cutan Pathol"},{"issue":"2","key":"2860_CR6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.5114\/ada.2017.72269","volume":"35","author":"A Owczarczyk-Saczonek","year":"2018","unstructured":"Owczarczyk-Saczonek A, Sokolowska-Wojdylo M, Olszewska B, Malek M, Znajewska-Pander A, Kowalczyk A, et\u00a0al. Clinicopathologic retrospective analysis of blastic plasmacytoid dendritic cell neoplasms. Postepy Dermatologii I Alergologii. 2018;35(2):128\u201338.","journal-title":"Postepy Dermatologii I Alergologii."},{"key":"2860_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(19)30602-1","author":"MC Bruggen","year":"2020","unstructured":"Bruggen MC, Valencak J, Stranzenbach R, Li N, Stadler R, Jonak C, et\u00a0al. Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicentre study. Eur J Cancer. 2020. https:\/\/doi.org\/10.1016\/S0959-8049(19)30602-1.","journal-title":"Eur J Cancer."},{"issue":"1","key":"2860_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1365-2133.2009.09373.x","volume":"162","author":"S Dalle","year":"2010","unstructured":"Dalle S, Beylot-Barry M, Bagot M, Lipsker D, Machet L, Joly P, et\u00a0al. Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice? Br J Dermatol. 2010;162(1):74\u20139.","journal-title":"Br J Dermatol"},{"key":"2860_CR9","doi-asserted-by":"publisher","DOI":"10.1177\/2040620719874733","author":"MP Economides","year":"2019","unstructured":"Economides MP, Konopleva M, Pemmaraju N. Recent developments in the treatment of blastic plasmacytoid dendritic cell neoplasm. Ther Adv Hematol. 2019. https:\/\/doi.org\/10.1177\/2040620719874733.","journal-title":"Ther Adv Hematol."},{"issue":"12","key":"2860_CR10","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1182\/blood-2015-10-612747","volume":"127","author":"GB McDonald","year":"2016","unstructured":"McDonald GB. How I treat acute graft-versus-host disease of the gastrointestinal tract and the liver. Blood. 2016;127(12):1544\u201350.","journal-title":"Blood"},{"key":"2860_CR11","doi-asserted-by":"publisher","unstructured":"Lim MS, Lemmert K, Enjeti A. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity. BMJ Case Rep. 2016;2016:bcr2015214093. https:\/\/doi.org\/10.1136\/bcr-2015-214093.","DOI":"10.1136\/bcr-2015-214093"},{"issue":"2","key":"2860_CR12","first-page":"5017","volume":"9","author":"X Xin","year":"2016","unstructured":"Xin X, Tian M, Huang LF, Wang GX, Cheng L, Liu ZJ, et\u00a0al. Cutaneous lesions from a blastic plasmacytoid dendritic cell neoplasm: a case report and literature review. Int J Clin Exp Med. 2016;9(2):5017\u201322.","journal-title":"Int J Clin Exp Med"},{"key":"2860_CR13","doi-asserted-by":"publisher","first-page":"692","DOI":"10.12659\/AJCR.903059","volume":"18","author":"C Barros Romao","year":"2017","unstructured":"Barros Romao C, Santos Junior CJD, Leite LAC, Gomes Alves MJR, Araujo NS, Castro AFL, et\u00a0al. Blastic plasmacytoid dendritic cell neoplasm with pulmonary involvement and atypical skin lesion. Am J Case Rep. 2017;18:692\u20135.","journal-title":"Am J Case Rep."},{"key":"2860_CR14","doi-asserted-by":"publisher","unstructured":"Lee SE, Park HY, Kwon D, Jeon YK, Kim WY. Blastic plasmacytoid dendritic cell neoplasm with unusual extracutaneous manifestation: two case reports and literature review. Medicine (Baltimore). 2019;98(6):e14344. https:\/\/doi.org\/10.1097\/MD.0000000000014344.","DOI":"10.1097\/MD.0000000000014344"},{"issue":"5","key":"2860_CR15","first-page":"8204","volume":"8","author":"N Ishibashi","year":"2015","unstructured":"Ishibashi N, Maebayashi T, Aizawa T, Sakaguchi M, Abe O, Miura K, et\u00a0al. Radiation therapy for cutaneous blastic plasmacytoid dendritic cell neoplasm: a case report and review of the literature. Int J Clin Exp Med. 2015;8(5):8204\u20139.","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"2860_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/cyto.b.21761","volume":"98","author":"F Hamadeh","year":"2020","unstructured":"Hamadeh F, Awadallah A, Meyerson HJ, Beck RC. Flow cytometry identifies a spectrum of maturation in myeloid neoplasms having plasmacytoid dendritic cell differentiation. Cytom Part B-Clin Cytom. 2020;98(1):43\u201351.","journal-title":"Cytom Part B-Clin Cytom."},{"key":"2860_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/4984951","volume":"2017","author":"M Pennisi","year":"2017","unstructured":"Pennisi M, Cesana C, Cittone MG, Bandiera L, Scarpati B, Mancini V, et\u00a0al. A case of blastic plasmacytoid dendritic cell neoplasm extensively studied by flow cytometry and immunohistochemistry. Case Rep Hematol. 2017;2017:1\u20136.","journal-title":"Case Rep Hematol."},{"key":"2860_CR18","first-page":"547","volume":"94","author":"K Hwang","year":"2009","unstructured":"Hwang K, Park CJ, Chi HS, Jang S, Park SJ, Huh JR, et\u00a0al. Immunohistochemistry (CD123, CD56 AND CD4) reveals minimal bone marrow involvement in cases of blastic plasmacytoid dendritic cell neoplasm. Haematologica Hematol J. 2009;94:547\u20138.","journal-title":"Haematologica Hematol J."},{"issue":"22","key":"2860_CR19","doi-asserted-by":"publisher","first-page":"5183","DOI":"10.1182\/blood.V128.22.5183.5183","volume":"128","author":"G Cesarman-Maus","year":"2016","unstructured":"Cesarman-Maus G, Lome C, Espinosa KA, Quezada-Fiallos CM, Rivas S, Quezda R. Clinical and pathological features and differential diagnosis of blastic plasmacytoid dendritic cell neoplasm (BPDCN): a series of cases. Blood. 2016;128(22):5183.","journal-title":"Blood"},{"key":"2860_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2147\/BLCTT.S132060","volume":"7","author":"AM Trottier","year":"2017","unstructured":"Trottier AM, Cerquozzi S, Owen CJ. Blastic plasmacytoid dendritic cell neoplasm: challenges and future prospects. Blood Lymphat Cancer. 2017;7:85\u201393.","journal-title":"Blood Lymphat Cancer."},{"issue":"4","key":"2860_CR21","first-page":"207","volume":"17","author":"N Pemmaraju","year":"2019","unstructured":"Pemmaraju N. Treatment advances in blastic plasmacytoid dendritic cell neoplasm. Clin Adv Hematol Oncol. 2019;17(4):207\u20139.","journal-title":"Clin Adv Hematol Oncol"},{"issue":"10","key":"2860_CR22","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1080\/17512433.2019.1662297","volume":"12","author":"MP Economides","year":"2019","unstructured":"Economides MP, McCue D, Lane AA, Pemmaraju N. Tagraxofusp, the first CD123-targeted therapy and first targeted treatment for blastic plasmacytoid dendritic cell neoplasm. Expert Rev Clin Pharmacol. 2019;12(10):941\u20136.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"3","key":"2860_CR23","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1182\/blood-2014-04-566737","volume":"124","author":"AE Frankel","year":"2014","unstructured":"Frankel AE, Woo JH, Ahn C, Pemmaraju N, Medeiros BC, Carraway HE, et\u00a0al. Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients. Blood. 2014;124(3):385\u201392.","journal-title":"Blood"},{"issue":"17","key":"2860_CR24","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1056\/NEJMoa1815105","volume":"380","author":"N Pemmaraju","year":"2019","unstructured":"Pemmaraju N, Lane AA, Sweet KL, Stein AS, Vasu S, Blum W, et\u00a0al. Tagraxofusp in blastic plasmacytoid dendritic-cell neoplasm. N Engl J Med. 2019;380(17):1628\u201337.","journal-title":"N Engl J Med"},{"issue":"2","key":"2860_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/14712598.2020.1701651","volume":"20","author":"M Alfayez","year":"2020","unstructured":"Alfayez M, Konopleva M, Pemmaraju N. Role of tagraxofusp in treating blastic plasmacytoid dendritic cell neoplasm (BPDCN). Expert Opin Biol Ther. 2020;20(2):115\u201323.","journal-title":"Expert Opin Biol Ther"},{"issue":"3","key":"2860_CR26","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1016\/j.bbmt.2019.12.612","volume":"26","author":"MH Qazilbash","year":"2020","unstructured":"Qazilbash MH, Ramdial J, Bashir Q, Milton DR, Patel RD, Popat UR, et\u00a0al. Outcomes of allogeneic hematopoietic stem cell transplantation for BPDCN. Biol Blood Marrow Transplant. 2020;26(3):S106\u20137.","journal-title":"Biol Blood Marrow Transplant"},{"key":"2860_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-230332","author":"AM Khan","year":"2019","unstructured":"Khan AM, Munir A, Raval M, Mehdi S. Blastic plasmacytoid dendritic cell neoplasm in the background of myeloproliferative disorder and chronic lymphocytic leukaemia. BMJ Case Rep. 2019. https:\/\/doi.org\/10.1136\/bcr-2019-230332.","journal-title":"BMJ Case Rep."}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-02860-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-021-02860-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-02860-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T23:07:02Z","timestamp":1621724822000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-021-02860-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,23]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2860"],"URL":"https:\/\/doi.org\/10.1186\/s13256-021-02860-z","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2021,5,23]]},"assertion":[{"value":"23 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors state that consent for publication in print and electronically has been obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"292"}}